CVS Health Dirección
Dirección controles de criterios 3/4
El CEO de CVS Health's es Karen Lynch , nombrado en Feb 2021, tiene una permanencia de 3.17 años. compensación anual total es $21.62M, compuesta por 6.9% salario y 93.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.04% de las acciones de la empresa, por valor de $34.07M. La antigüedad media del equipo directivo y de la junta directiva es de 2.1 años y 6.2 años, respectivamente.
Información clave
Karen Lynch
Chief Executive Officer (CEO)
US$21.6m
Compensación total
| Porcentaje del salario del CEO | 6.9% |
| Permanencia del CEO | 3.3yrs |
| Participación del CEO | 0.04% |
| Permanencia media de la dirección | 2.2yrs |
| Promedio de permanencia en la Junta Directiva | 6.3yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10
CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20CVS Health Offers Recession-Resistant Growth With Transformation
Oct 05CVS Stock: The Risk-Reward Is In A Better Place
Sep 18Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$7b |
| Dec 31 2023 | US$22m | US$2m | US$8b |
| Sep 30 2023 | n/a | n/a | US$9b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$21m | US$1m | US$4b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$8b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$20m | US$1m | US$8b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$7b |
| Mar 31 2021 | n/a | n/a | US$7b |
| Dec 31 2020 | US$11m | US$1m | US$7b |
Compensación vs. Mercado: La compensación total de Karen($USD21.62M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD13.51M).
Compensación vs. Ingresos: La compensación de Karen ha sido consistente con los resultados de la empresa en el último año.
CEO
Karen Lynch (60 yo)
3.3yrs
Permanencia
US$21,615,034
Compensación
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.3yrs | US$21.62m | 0.040% $ 28.2m | |
| Executive VP & CFO | less than a year | US$4.58m | 0.0028% $ 2.0m | |
| Executive VP of Ventures and Chief Digital | 1.8yrs | US$8.88m | 0.0016% $ 1.1m | |
| Executive VP | 1.3yrs | US$11.89m | 0.00078% $ 546.6k | |
| Executive VP | 2.5yrs | US$8.58m | 0.0037% $ 2.6m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | sin datos | sin datos | |
| Senior VP | 5.5yrs | sin datos | 0.00068% $ 476.5k | |
| Senior Vice President of Business Development & Investor Relations | 1.8yrs | sin datos | sin datos | |
| Executive VP & Chief Compliance Officer | no data | sin datos | sin datos | |
| Executive VP & Chief People Officer | 3.3yrs | sin datos | 0.0030% $ 2.1m | |
| Executive Vice President & President of CVS Caremark | 1.3yrs | sin datos | 0.0032% $ 2.3m | |
| Executive VP and Chief Customer & Experience Officer | 3.3yrs | sin datos | 0.0099% $ 6.9m |
2.2yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CVS se considera experimentado (2.1 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.3yrs | US$21.62m | 0.040% $ 28.2m | |
| Independent Director | less than a year | US$195.42k | 0.00022% $ 154.2k | |
| Independent Director | 5.5yrs | US$314.00k | 0.0026% $ 1.8m | |
| Independent Chairman | 5.5yrs | US$576.50k | 0.00033% $ 231.2k | |
| Independent Director | 7yrs | US$301.50k | 0.00094% $ 658.7k | |
| Independent Director | 10.7yrs | US$321.50k | 0.0024% $ 1.6m | |
| Independent Director | 13.3yrs | US$321.50k | 0.0026% $ 1.8m | |
| Independent Director | 17.2yrs | US$321.50k | 0.0095% $ 6.7m | |
| Independent Director | 17.2yrs | US$321.50k | 0.0086% $ 6.0m | |
| Independent Director | 9.2yrs | US$301.50k | 0.00024% $ 168.2k | |
| Independent Director | 5.5yrs | US$318.17k | 0.0026% $ 1.8m | |
| Independent Director | 1.7yrs | US$301.50k | 0.00041% $ 287.3k |
6.3yrs
Permanencia media
67.5yo
Promedio de edad
Junta con experiencia: La junta directiva de CVS se considera experimentada (6.2 años de antigüedad promedio).